Citadel Advisors’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$194K Buy
90,900
+38,500
+73% +$91.6K ﹤0.01% 11445
2025
Q4
$127K Buy
+52,400
New +$186K ﹤0.01% 11451
2025
Q2
Sell
-17,000
Closed -$26.4K 12573
2025
Q1
$26.4K Buy
17,000
+4,600
+37% +$9.64K ﹤0.01% 12929
2024
Q4
$26.5K Sell
12,400
-76,000
-86% -$218K ﹤0.01% 12976
2024
Q3
$385K Buy
88,400
+81,300
+1,145% +$442K ﹤0.01% 8802
2024
Q2
$33.1K Buy
7,100
+2,100
+42% +$11.3K ﹤0.01% 12165
2024
Q1
$25.4K Sell
5,000
-100
-2% -$403 ﹤0.01% 12838
2023
Q4
$14.3K Sell
5,100
-6,600
-56% -$15.5K ﹤0.01% 12883
2023
Q3
$33.6K Buy
11,700
+7,900
+208% +$29.1K ﹤0.01% 12184
2023
Q2
$19.2K Buy
3,800
+3,100
+443% +$6.33K ﹤0.01% 12758
2023
Q1
$1.32K Sell
700
-24,000
-97% -$55.1K ﹤0.01% 14328
2022
Q4
$44.5K Sell
24,700
-42,600
-63% -$76.7K ﹤0.01% 12277
2022
Q3
$114K Buy
67,300
+27,700
+70% +$85.4K ﹤0.01% 10978
2022
Q2
$97K Buy
39,600
+18,200
+85% +$42.3K ﹤0.01% 11436
2022
Q1
$59K Buy
21,400
+2,700
+14% +$9.86K ﹤0.01% 12694
2021
Q4
$100K Sell
18,700
-17,700
-49% -$124K ﹤0.01% 12724
2021
Q3
$308K Sell
36,400
-10,600
-23% -$105K ﹤0.01% 11023
2021
Q2
$573K Buy
47,000
+31,000
+194% +$613K ﹤0.01% 9748
2021
Q1
$388K Buy
+16,000
New +$432K ﹤0.01% 10256

Other funds holding BDTX